Can remote care tame COPD Flare-Ups?

NCT ID NCT07751003

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests whether active remote management—where a respiratory therapist regularly reviews ventilator data and adjusts settings—can improve quality of life and reduce flare-ups in COPD patients with chronic hypercapnia using home breathing support. Participants are randomly assigned to either active remote management or passive monitoring alone, and are followed for 12 months. The study compares changes in quality-of-life scores and the number of acute exacerbations requiring medication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Remote management program (active monitoring and adjustment of home non-invasive respiratory support by a respiratory therapist)
What this could lead to
If effective, this approach could reduce COPD flare-ups and improve daily life for people on home breathing support, potentially easing hospital burden.
What could go wrong
The trial is relatively small and the benefit over standard monitoring is uncertain. Remote adjustments may not suit all patients, and technology or connectivity issues could limit effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE EXACERBATION OF COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, China

  • Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

    Hangzhou, Zhejiang, 310016, China

  • Taizhou Hospital of Integrated Traditional Chinese and Western Medicine

    Wenling, Zhejiang, 317523, China

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, 410006, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.